Please log in to view this page
Username
Password
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
